Redwire Aims Higher: Analyst Backs Space Firm’s Defense Expansion
Redwire Corporation (NYSE:RDW) is one of the best space stocks to buy according to hedge funds.
Insider Monkey Blog
Drones, Hypersonics, and Airbus: Kratos Becomes the Defense Market’s Dark Horse
Kratos Defense & Security Solutions. (NASDAQ:KTOS) is one of the best space stocks to buy according to hedge funds.
Lunar Ambitions Grow: Intuitive Machines Secures Expansion to Build the Next Generation of Space Infrastructure
Intuitive Machines, Inc. (NASDAQ:LUNR) is one of the best space stocks to buy according to hedge funds.
AST SpaceMobile Gets $59 Bullish Nod on Direct-to-Phone Satellite Ambitions
AST SpaceMobile (NASDAQ:ASTS) is one of the best space stocks to buy according to hedge funds.
Planet Labs Lands €240M German Contract, Expands Global Defense Footprint
Planet Labs (NYSE:PL) is one of the best space stocks to buy according to hedge funds.
Citi Lifts Rocket Lab Target to $50 on Neutron Momentum and Government Contracts
Rocket Lab USA, Inc. (NASDAQ:RKLB) is one of the best space stocks to buy according to hedge funds.
Iridium Gets $40 Target Ahead of Q2 as Cantor Backs Its IoT and D2D Expansion
Iridium Communications (NASDAQ:IRDM) is one of the best space stocks to buy according to hedge funds.
Northrop Grumman’s Space Mechanic Clears Milestone in DARPA-Backed Satellite Servicing Program
Northrop Grumman (NYSE:NOC) is one of the best space stocks to buy according to hedge funds.
Boeing Secures Strategic Satellite Deal, Cementing Role in U.S. Space Defense Infrastructure
Boeing (NYSE:BA) is one of the best space stocks to buy according to hedge funds. On July 3, 2025, Boeing secured a significant $2.8 billion contract with the U.S.
Truist Trims Lockheed Target but Reaffirms Buy on Defense Strength and Valuation Appeal
Lockheed Martin (NYSE: LMT) is one of the best space stocks to buy according to hedge funds.
Why Eli Lilly (LLY) is Emerging as a Dividend Growth Leader in Pharma for 2025
In the past five years, the company has raised its payouts at an annual average rate of 16%.
Thermo Fisher Scientific’s (TMO) Dividend: Steady Payouts in a Growing Market
The stock is down by over 21% since the start of 2025; however, it continues to be a strong long-term growth company, supported by its large scale, diverse operations, and steady...
Pfizer’s (PFE) Dividend Safety: Balancing Innovation and Shareholder Returns
Pfizer Inc. (NYSE:PFE) hasn’t performed well in recent years, with its stock declining more than 26% over the past decade.
Merck’s (MRK) Dividend History: A Track Record of Consistency
The company has a strong lineup of products in development and brings in solid revenue and earnings.
Johnson & Johnson’s (JNJ) Dividend Track Record: Reliability in Uncertain Times
Johnson & Johnson (NYSE:JNJ) has long been considered one of the most dependable dividend stocks, having increased its payouts for 63 consecutive years, including a 4.8% raise...
Why AbbVie (ABBV) Remains a Dividend Standout in the Pharma Sector
AbbVie Inc. (NYSE:ABBV) stands out as a major player in the pharmaceutical industry, with a broad range of approved treatments.
Why Gilead Sciences (GILD) Appeals to Income Investors in the Pharma Sector
The company rose to prominence during the COVID-19 pandemic thanks to its antiviral drug remdesivir, one of the earliest approved treatments for the virus.
Is Zoetis (ZTS) a Unique Dividend Play in the Pharma Space for 2025?
Zoetis Inc. (NYSE:ZTS) stands out as a top player in the animal health sector, offering a wide range of products for both livestock and pets.
CVS Health’s (CVS) Dividend Outlook: Can the Retail-Pharma Giant Deliver in 2025?
[caption id="attachment_1196201" align="aligncenter" width="1456"] A row of shelves in a retail pharmacy, demonstrating the variety of drugs and over-the-counter products.[/caption...
Is McKesson (MCK) an Overlooked Dividend Stock in the Pharma Sector for 2025?
In its fourth-quarter 2025 earnings announcement, the company revealed plans to spin off its Medical-Surgical Solutions segment into a separate entity, referred to as “NewCo...
How Abbott Laboratories (ABT) Balances Innovation with Shareholder Payouts
[caption id="attachment_1196376" align="aligncenter" width="1456"] An operating room with a doctor monitoring a patient's vital signs during surgery with a medical device.[/caption...
Why Amgen (AMGN) Could Be a Hidden Gem Among Dividend Pharma Stocks in 2025
In 2023, the company finalized its $28 billion acquisition of Horizon Therapeutics, a smaller biotech firm.
Why Income Investors Are Watching Bristol-Myers Squibb Company (BMY) in 2025
The company has dealt with some hurdles in the past, but it has secured several key new drug approvals in recent years.
Is AstraZeneca (AZN) a Reliable Dividend Stock for Long-Term Investors?
[caption id="attachment_1199068" align="aligncenter" width="1456"] A pharmacy worker distributing prescription medicines to patientsreceiving treatment for oncology, cardiovascular...
These 10 Stocks Surprisingly Lead Gains While Wall Street Naps
While the wider market capped off the trading week in a lackluster note, ten stocks notably boasted strong gains, thanks to company-specific developments that sparked buying appetite...
14 Best Pharma Dividend Stocks to Buy in 2025
The US pharmaceutical industry has undergone notable shifts in recent years, influenced by factors such as the COVID-19 pandemic, expanded collaborations across the value chain...
8 Stocks That Jim Cramer Recently Talked About
In a recent appearance on CNBC's Squawk on the Street, Jim Cramer discussed what bank industry executives were saying about President Trump removing Federal Reserve Chairman Jerome...
BofA Maintains a Sell Rating on GSK plc (GSK), Sets a PT of p1,510
GSK plc (NYSE:GSK) is one of the best cheap stocks under $50 to buy now.
Energy Transfer LP (ET) Gets Initiated With a New Buy Rating at TD Cowen
Energy Transfer LP (NYSE:ET) is one of the best cheap stocks under $50 to buy now.
Scotiabank Raises PT on Suncor Energy (SU) to C$60 From C$57, Keeps Sector Perform Rating
Suncor Energy Inc. (NYSE:SU) is one of the best cheap stocks under $50 to buy now. On July 11, Scotiabank raised the firm’s price target on Suncor Energy Inc.
RBC Capital Reiterates a Hold Rating on BP p.l.c. (BP), Sets a £4.50 Price Target
BP p.l.c. (NYSE:BP) is one of the best cheap stocks under $50 to buy now. On July 16, RBC Capital analyst Biraj Borkhataria maintained a Hold rating on BP p.l.c.
BMO Capital Maintains a Buy on Canadian Natural Resources (CNQ) With a C$56 PT
Canadian Natural Resources Limited (NYSE:CNQ) is one of the best cheap stocks under $50 to buy now.
BofA Raises PT on Truist Financial (TFC) to $50 From $46, Keeps a Buy Rating
Truist Financial Corporation (NYSE:TFC) is one of the best cheap stocks under $50 to buy now.
BofA Lifts PT on US Bancorp (USB) to $54 From $49, Maintains a Buy Rating
US Bancorp (NYSE:USB) is one of the best cheap stocks under $50 to buy now.
TD Cowen Reiterates a Buy Rating on Verizon Communications (VZ) With a $50 PT
Verizon Communications Inc. (NYSE:VZ) is one of the best cheap stocks under $50 to buy now.
Stifel Nicolaus Lowers Price Target on Schlumberger Limited (SLB) to $52, Keeps a Buy Rating
Schlumberger Limited (NYSE:SLB) is one of the best cheap stocks under $50 to buy now.
Morgan Stanley Maintains a Sell Rating on Bristol-Myers Squibb (BMY), Sets a $34 PT
Bristol-Myers Squibb Company (NYSE:BMY) is one of the best cheap stocks under $50 to buy now.
Morgan Stanley Lifts PT on AT&T (T) to $32, Keeps an Overweight Rating
AT&T Inc. (NYSE:T) is one of the best cheap stocks under $50 to buy now. On July 16, Morgan Stanley analyst Benjamin Swinburne raised the firm’s price target on AT&T Inc.
Morgan Stanley Maintains a Hold on Pfizer (PFE)
Pfizer Inc. (NYSE:PFE) is one of the best cheap stocks under $50 to buy now. On July 10, Morgan Stanley analyst Terrence Flynn reiterated a hold rating on Pfizer Inc.
Barclays Says Bank of America’s (BAC) Q2 Report “Positive” for Mastercard and Visa
Bank of America Corporation (NYSE:BAC) is one of the best cheap stocks under $50 to buy now.
HSBC Trims Amgen (AMGN) Price Target, Maintains Buy Rating
Amgen Inc. (NASDAQ:AMGN) is one of the high-margin pharma stocks to buy now. HSBC has lowered its price target on Amgen Inc.
Pfizer (PFE) and Bristol Myers (BMY) Launch Direct-to-Patient Eliquis Program
Pfizer, Inc. (NYSE:PFE) is one of the high-margin pharma stocks to buy now. Bristol-Myers Squibb Company (NYSE:BMY) and Pfizer, Inc.
Morgan Stanley Raises Royalty Pharma (RPRX) Price Target, Maintains Overweight Rating
Royalty Pharma plc (NASDAQ:RPRX) is one of the high-margin pharma stocks to buy now.
Jefferies Raises Merck (MRK) Price Target, Maintains Buy Rating
Merck & Company, Inc. (NYSE:MRK) is one of the high-margin pharma stocks to buy now. Jefferies has raised its price target on Merck & Co.
J.P. Morgan Sees Strong Q2 for Eli Lilly, Maintains Overweight Rating
Eli Lilly and Company (NYSE:LLY) is one of the high-margin pharma stocks to buy now.
Morgan Stanley Trims United Therapeutics (UTHR) Price Target, Maintains Buy Rating
United Therapeutics Corporation (NASDAQ:UTHR) is one of the high-margin pharma stocks to buy now.
Argus Trims Zoetis (ZTS) Price Target to $190, Keeps Constructive View
Zoetis Inc. (NYSE:ZTS) is one of the high-margin pharma stocks to buy now. Argus has trimmed its price target on Zoetis Inc.
Goldman Sachs Initiates Alkermes (ALKS) with a Buy Rating
Alkermes plc (NASDAQ:ALKS) is one of the high-margin pharma stocks to buy now.
Rothschild Raises AbbVie (ABBV) Price Target, Maintains Buy Rating
AbbVie Inc. (NYSE:ABBV) is one of the high-margin pharma stocks to buy now. AbbVie Inc.
Berenberg Maintains Novo Nordisk (NV) Price Target and Hold Rating
Novo Nordisk A/S (NYSE:NVO) is one of the high-margin pharma stocks to buy now.
Hedge Fund Resource Center
